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Background/Introduction
The NeoChord DS1000 is a disposable device used to
replace damaged chordae by delivering artificial chordae
tendinae in a beating heart through small anterolateral
thoracotomy. It gives alternative approach in treating
degenerative mitral valve insufficiency.
Aims/Objectives
To assess safety and efficacy in treating patients with
off-pump transapical neochord implantation in Vilnius
University.
Method
60 patients had underwent off pump transapical neo-
chord implantation. Patients were followed up to 1 year
with clinical and echocardioscopic examination.
Results
Out of 60 patients 48 (80%) had chordae implanted only
to P2 segment. 2 (3%) patients had chordae implanted
only to A2 segment. All other patients had chordae
implanted to multiple segments. The average patient age
was 60 ± 12 years, Euroscore II - 1,2 ± 1%. Median
duration of operation was 129 ± 27 min. The mean
intraoperative blood loss was 700 ± 500 ml, mean post-
operative drainage was 230 ± 120 ml. Three (6%)
patients needed RBC transfusion, 1 (2%) patient needed
FFP transfusion. One patient required permanent pace-
maker implantation due to sick sinus syndrome. There
were no re-explorations for bleeding, strokes, new renal
failure, wound infections or deaths. Acute procedure
success was achieved in 58 (97%) of patients.52 patients
had reached 6 months follow up and 33 patients have
reached 12 months follow up. In patients with P2 pro-
lapse without prolapse extension towards the commis-
sures or central component to regurgitant jet or lack of
central cooptation the mitral valve insufficiency less
than 2+ remained in 94% (36 out of 38) patients at six
months and 92 % (22 out 24) at 12 months follow up.
In patients with prolapse extension towards the com-
missures or with central component to regurgitant jet or
lack of central cooptation the mitral valve insufficiency
less than 2+ was achieved in 50% (6 out of 12) patients at
six months and 50% (4 out 8) at 12 months follow up.
Discussion/Conclusion
Off-pump transapical implantation of artificial chordae
with NeoChord device is a safe method for the treat-
ment of mitral valve insufficiency and preserves conven-
tional MV repair treatment options if unsuccessful.
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